First Trust Direct Indexing’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-22,901
Closed -$488K 336
2024
Q3
$488K Buy
22,901
+2,021
+10% +$39.8K 0.03% 558
2024
Q2
$399K Sell
20,880
-1,384
-6% -$28.2K 0.02% 567
2024
Q1
$429K Sell
22,264
-1,294
-5% -$25.6K 0.03% 509
2023
Q4
$491K Sell
23,558
-330
-1% -$6.34K 0.04% 444
2023
Q3
$515K Buy
23,888
+1,482
+7% +$36K 0.06% 387
2023
Q2
$536K Sell
22,406
-528
-2% -$12.1K 0.06% 394
2023
Q1
$488K Buy
22,934
+174
+0.8% +$3.33K 0.06% 406
2022
Q4
$372K Buy
22,760
+4,875
+27% +$72.3K 0.05% 454
2022
Q3
$251K Buy
+17,885
New +$338K 0.04% 514
2021
Q1
Sell
-683
Closed -$28K 600
2020
Q4
$28K Buy
+683
New +$28.5K 0.01% 838

Other funds holding FMS

First Trust Direct Indexing's FMS Position: Q4 2024 in Review

First Trust Direct Indexing sold out of Fresenius Medical Care (FMS) in Q4 2024, closing a stake of 22,901 shares — an estimated $488K sold.

First Trust Direct Indexing first reported a position in FMS in Q4 2020 and held it in 10 quarters. The position peaked at $536K in Q2 2023. 189 funds tracked by Wall St. Rank hold FMS as of Q4 2024.

  • First Trust Direct Indexing reported no remaining Fresenius Medical Care position as of Q4 2024 after selling out during the quarter.
  • First Trust Direct Indexing sold 22,901 Fresenius Medical Care shares in Q4 2024, an estimated $488K.
  • First Trust Direct Indexing first reported a position in Fresenius Medical Care in Q4 2020 and held it in 10 quarters.
  • First Trust Direct Indexing's Fresenius Medical Care position peaked at $536K in Q2 2023.
  • 189 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q4 2024.

Based on First Trust Direct Indexing's 13F filing for Q4 2024.